DE69834262D1 - Neue pharnazeutische verwendung von c-c chemokin produktionsinhibitoren - Google Patents

Neue pharnazeutische verwendung von c-c chemokin produktionsinhibitoren

Info

Publication number
DE69834262D1
DE69834262D1 DE69834262T DE69834262T DE69834262D1 DE 69834262 D1 DE69834262 D1 DE 69834262D1 DE 69834262 T DE69834262 T DE 69834262T DE 69834262 T DE69834262 T DE 69834262T DE 69834262 D1 DE69834262 D1 DE 69834262D1
Authority
DE
Germany
Prior art keywords
chemokin
pharmaceutical use
new pharmaceutical
production inhibitors
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69834262T
Other languages
English (en)
Other versions
DE69834262T2 (de
Inventor
Hajimu Kurumatani
Rie Sasaki
Hiroki Kumagai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Application granted granted Critical
Publication of DE69834262D1 publication Critical patent/DE69834262D1/de
Publication of DE69834262T2 publication Critical patent/DE69834262T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69834262T 1997-09-16 1998-09-16 C-C Chemokine Produktionsinhibitoren Expired - Lifetime DE69834262T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25096697 1997-09-16
JP25096697 1997-09-16
PCT/JP1998/004164 WO1999013880A1 (fr) 1997-09-16 1998-09-16 Inhibiteur de la production de chemokine c-c

Publications (2)

Publication Number Publication Date
DE69834262D1 true DE69834262D1 (de) 2006-05-24
DE69834262T2 DE69834262T2 (de) 2006-09-07

Family

ID=17215679

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69834262T Expired - Lifetime DE69834262T2 (de) 1997-09-16 1998-09-16 C-C Chemokine Produktionsinhibitoren

Country Status (5)

Country Link
EP (1) EP1016408B1 (de)
JP (1) JP4314742B2 (de)
CA (1) CA2303343C (de)
DE (1) DE69834262T2 (de)
WO (1) WO1999013880A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2304955T3 (es) * 1999-05-10 2008-11-01 Toray Industries, Inc. Medicamentos contra la insuficiencia renal.
US20030092760A1 (en) 2001-03-12 2003-05-15 Toray Industries, Inc. Therapeutic agent for renal failure
JP2004517078A (ja) * 2000-12-01 2004-06-10 シェーリング　コーポレイション 哺乳動物遺伝子および関連試薬の使用
DE10225551A1 (de) * 2002-06-06 2003-12-24 Schering Ag Verwendung von oral verfügbaren Prostacyclinderivaten für die Herstellung eines Arzneimittels zur Behandlung von Krankheiten, die mit Knochenmarködemen assoziiert sind
EP1627638B1 (de) * 2003-05-09 2017-07-12 Toray Industries, Inc. Beraprost und ein inhibitor des renin-angiotensin-systems zur verwendung bei der behandlung von nierenerkrankungen
WO2007007668A1 (ja) * 2005-07-08 2007-01-18 Toray Industries, Inc. ***改善のための治療剤および処置方法
CA2744391A1 (en) * 2008-12-05 2010-06-10 Intermed Discovery Gmbh Inhibitors of hif-1 protein accumulation
CN102655866B (zh) 2009-11-13 2013-11-13 东丽株式会社 糖尿病的治疗或预防药
TW201713575A (zh) 2015-09-30 2017-04-16 陶氏全球科技有限責任公司 具有乙烯／α－烯烴多嵌段共聚物的配件

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5931510B2 (ja) * 1979-09-03 1984-08-02 東レ株式会社 ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
JPS57144276A (en) * 1981-03-03 1982-09-06 Toray Ind Inc 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivative
EP0365678B1 (de) * 1987-10-16 1994-01-05 Toray Industries, Inc. 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG
JPH07188205A (ja) * 1993-12-27 1995-07-25 Ishihara Sangyo Kaisha Ltd α−グルコシダーゼ阻害剤

Also Published As

Publication number Publication date
DE69834262T2 (de) 2006-09-07
JP4314742B2 (ja) 2009-08-19
CA2303343A1 (en) 1999-03-25
EP1016408A1 (de) 2000-07-05
EP1016408A4 (de) 2003-03-05
CA2303343C (en) 2011-01-04
WO1999013880A1 (fr) 1999-03-25
EP1016408B1 (de) 2006-04-19

Similar Documents

Publication Publication Date Title
ATE239011T1 (de) Neuartige form von s-omeprazol
DE19681286T1 (de) Neue Kristallform von Olanzapin
DE69821072D1 (de) Echtzeit bildgesteuerte Positionierung von Verankerungseinheiten
DE69813616D1 (de) Cyclohexencarboxylate als inhibitoren der neuraminidase
DE69927128D1 (de) Verwendung von topisch applizierbaren Gerinnungsmaterial
DE69822186D1 (de) Herstellung von mustern
DE59905858D1 (de) Verwendung von pit-emulsionen
DE60041145D1 (de) Nutzung von daten
DE69633333D1 (de) Diphosphonatderivate von therapeutischen substanzen
ATE263147T1 (de) Derivate von aryloxyarylsulfonylamino hydroxyaminsäuren
DE60033896D1 (de) Unterscheidung von Modulationsarten
DE50012379D1 (de) Verwendung von nanoskaligen antischuppenwirkstoffen
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
ATE293477T1 (de) Neue verwendung von lipase-inhibitoren
ATE315383T1 (de) Beschichtung von tablettenkernen
FI971784A (fi) Apolipoproteiini B-synteesin estäjiä
DE69613818D1 (de) Inhibierung von hydratbildung
NO983632L (no) Krystallform av N-(4-trifluormetylfenyl)-5-metyl-isoksazol-4-karboksamid
ID22650A (id) Penggunaan penghambat-penghambat lipase usus lambung
EE9700093A (et) Apolipoproteiin-B sünteesi inhiibitorid
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
ID26137A (id) Komposisi farmasi baru dari uridin trifosfat
DE69801878D1 (de) Verwendung von Oxamatderivaten als Depigmentierungsmittel
DE69629962D1 (de) Inhibierung von Exoprotein in absorbierenden Produkten
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition